Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Committees and advisory bodies (384)
- Scheduling (national classification system) (166)
- Safety monitoring and information (27)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
384 result(s) found, displaying 201 to 225
-
Meeting statementsDetails about meeting 1 for the medical device reform consumer working group held in 2019.
-
Meeting statementsDetails about meeting 4 for the medical device reform consumer working group held in 2020.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Scheduling submissionsPublic submissions made in response to the proposed amendments to the Poisons Standard published on 26 August 2020
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 10 November 2020
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Scheduling submissionsPublic submissions made in response to the interim decisions published on 9 September 2020
-
Scheduling submissionsPublic submissions made in response to the interim decision on nicotine scheduling published on 23 September 2020
-
Scheduling decisions (final)Public notice of the delegate's final decision to amend the current Poisons Standard in relation to nicotine
-
Scheduling decisions (final)Public notice of the delegate's final decision to amend the Poisons Standard in relation to cannabidiol (private application and delegate initiated) - Joint ACMS-ACCS #25 and #26 (June and November 2020).
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsA meeting of the Therapeutic Goods Advertising Consultative Committee was held on 19 November 2020
-
Scheduling decisions (final)Final decisions on proposed amendments to the Poisons Standard - ACMS #31 (June 2020) and delegate only decisions relating to chemicals for agricultural and veterinary uses.
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAustralian Influenza Vaccine Committee (AIVC) recommendations
-
Scheduling submissionsPublic submissions on matters referred to the March 2020 scheduling meetings, and received during the interim consultation period - melatonin
-
Scheduling decisions (final)Public notice of the Delegates' final decisions to amend (or not amend) the current Poisons Standard in relation to melatonin.
-
Scheduling submissionsPublic submissions on scheduling matters referred to the Joint ACMS-ACCS #25 meetings held in June 2020 - Nicotine